Literature DB >> 10733923

Nuclear localization signals of the BRCA2 protein.

K Yano1, K Morotomi, H Saito, M Kato, F Matsuo, Y Miki.   

Abstract

BRCA2 is a tumor suppressor gene whose germline mutations increase the lifetime risk of breast cancer. BRCA2 encodes a large nuclear protein involved in DNA repair, but the location of its functional domain has been unclear. Here, we report nuclear localization signals (NLSs) of the BRCA2 protein. By expressing various portions of the BRCA2 protein tagged with enhanced green fluorescent protein in HeLa cells, we show that the C-terminal domain is necessary for nuclear localization. Two regions in the C-terminal domain were identified with functional NLSs by site-directed mutagenesis analyses. The NLSs locate between the germline mutation found in the most downstream position and the polymorphic stop codon, suggesting that defects in the proper nuclear transport of the BRCA2 protein are causative of carcinogenesis. Our data thus provide a possible explanation for the high frequency of frame-shift and nonsense mutations in BRCA2 of hereditary breast cancer patients. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10733923     DOI: 10.1006/bbrc.2000.2392

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  20 in total

1.  Genetic variations of BRCA1 and BRCA2 genes in dogs with mammary tumours.

Authors:  S O Enginler; I Akış; T S F Toydemir; K Oztabak; D Haktanir; M C Gündüz; I Kırşan; I Fırat
Journal:  Vet Res Commun       Date:  2013-10-13       Impact factor: 2.459

2.  Multiple nuclear localization signals mediate nuclear localization of the GATA transcription factor AreA.

Authors:  Cameron C Hunter; Kendra S Siebert; Damien J Downes; Koon Ho Wong; Sara D Kreutzberger; James A Fraser; David F Clarke; Michael J Hynes; Meryl A Davis; Richard B Todd
Journal:  Eukaryot Cell       Date:  2014-02-21

3.  Genome annotation by shotgun inactivation of a native gene in hemizygous cells: application to BRCA2 with implication of hypomorphic variants.

Authors:  Soma Ghosh; Anil K Bhunia; Bogdan C Paun; Samuel F Gilbert; Urmil Dhru; Kalpesh Patel; Scott E Kern
Journal:  Hum Mutat       Date:  2015-02       Impact factor: 4.878

4.  A novel loss-of-function heterozygous BRCA2 c.8946_8947delAG mutation found in a Chinese woman with family history of breast cancer.

Authors:  Jing Ma; Jichun Yang; Wenjing Jian; Xianming Wang; Deyong Xiao; Wenjun Xia; Likuan Xiong; Duan Ma
Journal:  J Cancer Res Clin Oncol       Date:  2017-01-05       Impact factor: 4.553

Review 5.  Functional assays for analysis of variants of uncertain significance in BRCA2.

Authors:  Lucia Guidugli; Aura Carreira; Sandrine M Caputo; Asa Ehlen; Alvaro Galli; Alvaro N A Monteiro; Susan L Neuhausen; Thomas V O Hansen; Fergus J Couch; Maaike P G Vreeswijk
Journal:  Hum Mutat       Date:  2013-12-03       Impact factor: 4.878

6.  Identification and functional analysis of NOL7 nuclear and nucleolar localization signals.

Authors:  Guolin Zhou; Colleen L Doçi; Mark W Lingen
Journal:  BMC Cell Biol       Date:  2010-09-27       Impact factor: 4.241

7.  Inherited BRCA2 mutations in African Americans with breast and/or ovarian cancer: a study of familial and early onset cases.

Authors:  Yasmine Kanaan; Elikem Kpenu; Kim Utley; Lucile Adams-Campbell; Georgia M Dunston; Lawrence C Brody; Carolyn Broome
Journal:  Hum Genet       Date:  2003-08-26       Impact factor: 4.132

8.  Restoration of CAPAN-1 cells with functional BRCA2 provides insight into the DNA repair activity of individuals who are heterozygous for BRCA2 mutations.

Authors:  Jeffrey T Holt; William P Toole; Vedang R Patel; HeeYoung Hwang; Erika T Brown
Journal:  Cancer Genet Cytogenet       Date:  2008-10-15

9.  Cancer-causing BRCA2 missense mutations disrupt an intracellular protein assembly mechanism to disable genome maintenance.

Authors:  Miyoung Lee; David Shorthouse; Robert Mahen; Benjamin A Hall; Ashok R Venkitaraman
Journal:  Nucleic Acids Res       Date:  2021-06-04       Impact factor: 16.971

10.  Reduced canine BRCA2 expression levels in mammary gland tumors.

Authors:  Yasunaga Yoshikawa; Masami Morimatsu; Kazuhiko Ochiai; Toshina Ishiguro-Oonuma; Seiichi Wada; Koichi Orino; Kiyotaka Watanabe
Journal:  BMC Vet Res       Date:  2015-07-23       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.